Search results
Neuropathology and molecular diagnosis of Synucleinopathies. S Koga, H Sekiya, N Kondru, OA Ross, DW Dickson. Molecular neurodegeneration 16 (1), 83. , 2021. 160. 2021. Truncated stathmin-2 is a marker of TDP-43 pathology in frontotemporal dementia. M Prudencio, J Humphrey, S Pickles, AL Brown, SE Hill, JM Kachergus, ...
Shunsuke Koga; Nha Trang Thu Pham [...] Keith A Josephs; Background: Globular glial tauopathy (GGT) has been associated with frontotemporal dementia syndromes; little is known about the clinical ...
Department of Pathology and Laboratory Medicine. Perelman School of Medicine at the University of Pennsylvania 3400 Spruce St. Philadelphia, PA 19104-4238
Others named Shunsuke Koga. Shunsuke Koga Inazma Inc. - CEO Tokyo. 古賀俊輔 株式会社ザフール - 代表取締役プロデューサー Kanagawa, Japan. 2 others named Shunsuke Koga are on ...
- 129
- Mayo Clinic
- Chiba University, Graduate School of Medicine
Email Koga.Shunsuke mayo edu; 2009 2024. Research activity per year. Overview; Fingerprint; Network; Research output (123) Similar Profiles (1) Fingerprint.
Affiliations. 1 Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104, United States. Electronic address: shunsuke.koga@pennmedicine.upenn.edu. 2 Department of Pathology and Laboratory Medicine, Hospital of the University of Pennsylvania, 3400 Spruce Street ...
The research of Shunsuke Koga, M.D., Ph.D., is focused on understanding the clinicopathological correlations of tauopathies and α-synucleinopathies, with a particular focus on progressive supranuclear palsy (PSP), corticobasal degeneration (CBD) and multiple system atrophy (MSA). Specifically, Dr. Koga investigates how comorbid pathologies, such as TDP-43 and Alzheimer's-type pathology, modify clinical presentations of patients with PSP, CBD and MSA.
